Arbutamine stimulation detects viable myocardium 4 weeks after coronary occlusion

Journal of the American Society of Echocardiography

Volumn 14, Issue 2, 2001, Pages 138-148

  Kisanuki, Akira ^b   Segar, Douglas S ^a   Ryan, Thomas ^a   Johnson, Michael ^a   Tei, Chuwa ^b   Feigenbaum, Harvey ^a   Sawada, Stephen G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARBUTAMINE; DOBUTAMINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CHRONOTROPISM; DOG; DRUG POTENCY; ECHOCARDIOGRAPHY; FUNCTIONAL ASSESSMENT; HEART INFARCTION; HEART STIMULATION; INOTROPISM; NONHUMAN; PREDICTION;

EID: 0035138866     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1067/mje.2001.108932     Document Type: Article

References (35)

1. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
2. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
3. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
4. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
5. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease
6. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction
7. Prediction of recovery of myocardial dysfunction after revascularization; comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography
8. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: Implications of time course of recovery on diagnostic accuracy
9. Dobutamine: Development of a new catecholamine to selectively increase cardiac contractility
10. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: An experimental evaluation
11. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenosis
12. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction
13. Dobutamine echocardiography in myocardial hibernation: Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty
14. Physiologic responses to epinephrine infusion: The basis for a new stress test for coronary artery disease
15. Use of the epinephrine test in diagnosis of coronary artery disease
16. Isoproterenol infusion stress two-dimensional echocardiography in diagnosis of coronary artery disease in elderly patients: Comparison with other stress testing methods
17. Evaluation of isoproterenol as a method of stress testing
18. Characterization of arbutamine: A novel catecholamine stress agent for diagnosis of coronary artery disease
19. Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemia
20. Hemodynamic effect of arbutamine
21. Arbutamine echocardiography: Efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease
22. Adequacy of low-stress arbutamine to provoke myocardial ischemia during echocardiography
23. Assessment of hibernating myocardium by dobutamine stimulation in a canine model
24. Statistical methods for assessing agreement between two methods of clinical measurement
25. Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium
26. Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography
27. Mechanisms of chronic regional postischemic dysfunction in humans: New insights from the study of noninfarcted collateral-dependent myocardium
28. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease
29. Pathophysiology of chronic left ventricular dysfunction: New insights from the measurement of absolute myocardial blood flow and glucose utilization
30. Chronic myocardial hibernation in humans: From bedside to bench
31. A canine model of chronic ischemic cardiomyopathy: Characterization of regional flow-function relations
32. "Hibernating" myocardium: Asleep or part dead?
33. Dependency of contractile reserve on myocardial blood flow: Implications for the assessment of myocardial viability with dobutamine stress echocardiography
34. Quantification of myocardial thickening. Doppler stroke volumes and ejection fraction in normal subjects during dobutamine stress echocardiography
35. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization